guided percutaneous biopsy of retroperitoneal lesions

29
GUIDED PERCUTANEOUS BIOPSY OF RETROPERITONEAL LESIONS Medical Imaging Departement; La Rabta Hospital INTV11

Upload: gay

Post on 03-Feb-2016

62 views

Category:

Documents


0 download

DESCRIPTION

INTV11. GUIDED PERCUTANEOUS BIOPSY OF RETROPERITONEAL LESIONS. Medical Imaging Departement; La Rabta Hospital. INTRODUCTION. Percutaneous fine-needle aspiration biopsy (PFNAB) under computed tomographic (CT) guidance has proved to be a widely accepted method of documenting malignancy. - PowerPoint PPT Presentation

TRANSCRIPT

Page 1: GUIDED PERCUTANEOUS  BIOPSY OF RETROPERITONEAL LESIONS

GUIDED PERCUTANEOUS BIOPSY OF RETROPERITONEAL LESIONS

Medical Imaging Departement; La Rabta Hospital

INTV11

Page 2: GUIDED PERCUTANEOUS  BIOPSY OF RETROPERITONEAL LESIONS

INTRODUCTION

Percutaneous fine-needle aspiration biopsy (PFNAB) under computed tomographic (CT) guidance has proved to be a widely accepted method of documenting malignancy.

Refinements in technique, experience with the procedure, and improvements in CT scanners have permitted a high degree of accuracy.

We present our experience over a 8-year period with this technique.

Page 3: GUIDED PERCUTANEOUS  BIOPSY OF RETROPERITONEAL LESIONS

OBJECTIVES

The aim of this work is to present an overview of Indication of percutanous needle biopsy which include diagnosis of primary or metastatic malignacy in a newly

discovered mass, diagnosis of tumor recurrence in patients known with malignancy diagnosis of infection and benign disease.

Page 4: GUIDED PERCUTANEOUS  BIOPSY OF RETROPERITONEAL LESIONS

PATIENTS AND METHODS

we retrospectivly reviewed percutaneous retroperitoneal biopsies performed in 49 patients between 2008 and 2011.

All biopsies were performed by the radiology staff in the imaging department La Rabta.

Biopsies were performed under CT guidance: helical CT (Tomoscan CX / S).

Page 5: GUIDED PERCUTANEOUS  BIOPSY OF RETROPERITONEAL LESIONS

PATIENTS AND METHODS

The decision of the percutaneous biopsy was multidisciplinary, taking into account : the report risk / benefit technical feasibility of the procedure.

Patients were informed of the nature of the act and its possible risks and especially the importance of their cooperation.

procedures were done under local anesthesia

Hemostasis tests were performed before the procedure.

Page 6: GUIDED PERCUTANEOUS  BIOPSY OF RETROPERITONEAL LESIONS

RESULTS

biopsy concerned renal masses in 12 cases revealing:

Histological typePatients

Carcinoma5

liposarcoma1

lymphoma.3

xanthogranulomatous pyelonephritis

1

Page 7: GUIDED PERCUTANEOUS  BIOPSY OF RETROPERITONEAL LESIONS

RESULTS

In 8 of the 49 patients with retropenitoneal abnormalities, metastatic

neoplasm was diagnosed, the primitive tumour was :

organcases

pancreas3

kidney2

lung1

Urinary tract1

Undetermined1

Page 8: GUIDED PERCUTANEOUS  BIOPSY OF RETROPERITONEAL LESIONS

RESULTS

Biopsy of a retro-peritoneal mass in 32 patients was :

naturecases

Lymphoma17

metastasis8

Retroperitoneal fibrosis

4

•In two of five adrenal biopsy pulmonary metastasis was shown.

Page 9: GUIDED PERCUTANEOUS  BIOPSY OF RETROPERITONEAL LESIONS

RESULTS

• In 9 cases tissue obtained was inadequate for diagnosis: • insufficient sample in 4.

• hemorrhagic or necrotic in 2.

• normal parenchyma in 3.

• In two of five adrenal biopsy pulmonary metastasis was shown.

Page 10: GUIDED PERCUTANEOUS  BIOPSY OF RETROPERITONEAL LESIONS

By side biopsy of an unresectable medial renal mass.

Biopsy of a left lower pole renal mass avoiding the necrotic component.

Page 11: GUIDED PERCUTANEOUS  BIOPSY OF RETROPERITONEAL LESIONS

Biopsy of the hypodense right renal mass. Confirmation of the diagnosis of lymphoma.

Trans-hepatic adrenal mass biopsy confirming its metastatic origin

in a patient with a primitive lung.

Page 12: GUIDED PERCUTANEOUS  BIOPSY OF RETROPERITONEAL LESIONS

Discussion In our institution, most abdominal aspiration procedures during

the past 9 years were performed under CT control.

CT permits accurate placement of a needle tip into small lesions, and its proximity to major vessels is readily ascertained.

The cross-sectional format of CT permits choice of the most appropriate needle approach to a suspected abnormality (i.e. , anterior, posterior, lateral, or oblique)

The skin puncture site, needle path, and depth can be readily determined from hard copy images and the measured depth for sampling directly transposed to the needle with a sterile rule.

Page 13: GUIDED PERCUTANEOUS  BIOPSY OF RETROPERITONEAL LESIONS

DISCUSSION Problems related to patient size, bowel gas, dressings and patient

positioning, can all be accommodated by the CT guidance procedure.

As the contraindications to CT-guided biopsy the lack of patient cooperation, coagulation problems technical impossibility due to interruption by major vessels and bowel

are noted.

Page 14: GUIDED PERCUTANEOUS  BIOPSY OF RETROPERITONEAL LESIONS

DISCUSSION

CT-guided biopsy was not indicated in a case that the envisaged path direction was not considered to be safe due to interruption by major vessels, bowel and vertebral bodies

enough specimens from the small lesions located at a deep site should be obtained with satisfactory sample for histological examination

Page 15: GUIDED PERCUTANEOUS  BIOPSY OF RETROPERITONEAL LESIONS

DISCUSSION

There is a wide variety of needles from which to choose, with various needle gauges, tip configurations, and sampling mechanisms.

For this discussion, they will be divided into three general groups: small-gauge aspiration needles such as the Chiba: cytology study small-guage cutting-core-biopsy needles : difficult path or high hemorrhagic risk larger cutting needles such as the 18-gauge Menghini, 18-gauge Biopty, and 14-gauge TruCut.

Page 16: GUIDED PERCUTANEOUS  BIOPSY OF RETROPERITONEAL LESIONS

DISCUSSION

Factors to consider when choosing a needle include location of the lesion, proximity to other structures, amount of tissue needed (pathologist’s needs), operator preference.

Aspiration needles are designed to obtain cytologic samples only. Occasionally, they obtain small pieces of tissue, which can be processed for histologic examination.

Page 17: GUIDED PERCUTANEOUS  BIOPSY OF RETROPERITONEAL LESIONS

Guillotine needle with deployed stylet. (b): the tissue core in biopsy needle.

Guillotine needle type tru-cut; chisel tip mandrel bent and made

Page 18: GUIDED PERCUTANEOUS  BIOPSY OF RETROPERITONEAL LESIONS

After skin marking the puncture site, disinfection and local anesthesia, the first needle carrier is introduced to the periphery of the mass.

(b) Performing the biopsy needle through the mandrel.

Page 19: GUIDED PERCUTANEOUS  BIOPSY OF RETROPERITONEAL LESIONS

Discussion

Before performing any biopsy, the previous diagnostic studies should be reviewed, and the clinical findings and information sought should be discussed with the referring physician in order to plan the most appropriate procedure.

Review of the previous diagnostic studies is helpful in selecting the imaging technique, approach, and positioning of the patient for the biopsy.

Page 20: GUIDED PERCUTANEOUS  BIOPSY OF RETROPERITONEAL LESIONS

Discussion

With CT guidance, most lesions are best approached by choosing a needle path that minimizes the skin-to-lesion distance.

When this involves traversing bowel or other organs, and when an alternative route is available, the alternative route is often chosen to avoid these other structures.

However, with thin-needle aspirations in the immunocompetent patient, it is possible to cross bowel, stomach, liver, or other structures without unacceptable risks

Page 21: GUIDED PERCUTANEOUS  BIOPSY OF RETROPERITONEAL LESIONS

Schematic representation of different possible approaches and organs that can be climbed during percutaneous gestures.

Page 22: GUIDED PERCUTANEOUS  BIOPSY OF RETROPERITONEAL LESIONS

Discussion

For ease of performance, it is best if the needle path lies in the axial plane.

This allows the entire needle to be visualized on a single image.

However, other structures often surround the lesion and preclude such an approach.

Several authors have described methods used to approach lesions that were not accessible via a direct approach.

Page 23: GUIDED PERCUTANEOUS  BIOPSY OF RETROPERITONEAL LESIONS

DISCUSSION otherwise inaccessible lesions cqn be approached

either from above or below and using a geometric approach to calculate the needle angle (the so-called “triangulation method”), many ons can be sampled safely.

This is especially valuable in renal, superior retroperitoneal adrenal lesions

when avoiding the caudal extent of the pleura is important to diminish the risk of pneumothorax, pleural contamination, malignant seeding of the pleural space.

Page 24: GUIDED PERCUTANEOUS  BIOPSY OF RETROPERITONEAL LESIONS

DISCUSSION

RENAL BIOPSY:

We can divide the indications for biopsy of renal masses in two groups:

Established indications for which there is a sufficient experience

Emerging indications that the biopsy remains a topic of discussion and controversy

Page 25: GUIDED PERCUTANEOUS  BIOPSY OF RETROPERITONEAL LESIONS

DISCUSSIONEstablished indications :

1.Atypical renal cell carcinoma: it may be cystic lesion, with fatty component or a low vascular mass.

2.An unresectable mass which malignancy is not established.

3.Suspicion of lymphoma.

4.The patient with high surgical risk.

5.A mass, in which the infectious origin is suspected.

Emerging indication:

1.Homogeneous, not cystic renal mass seen on ultrasound.

2.A complex cystic mass

3.Treatment by radiofrequency or cryo-ablation is discussed

Page 26: GUIDED PERCUTANEOUS  BIOPSY OF RETROPERITONEAL LESIONS

DISCUSSIONADRENAL BIOPSY

This biopsy is associated with a high rate of complication and the negative predictive value (80%).

On the other hand negative biopsy does not allow to formally eliminate the possibility of a metastasis, or to differentiate between adenoma and adenocarcinoma.

The current indications for adrenal biopsy are:

1.The indeterminate lesions discovered incidentally.

2.A mass with a relative percentage of wash out upper or equal to 50%.

3.A benign-looking lesion but increased in size.

Page 27: GUIDED PERCUTANEOUS  BIOPSY OF RETROPERITONEAL LESIONS

DISCUSSION

LYMH NODE BIOPSY

1.Suspicion of lymphoma.

2.Lymphoma and residual masses after treatment.

3.The metastasis, Infectious or during a granulomatous lymph node.

Page 28: GUIDED PERCUTANEOUS  BIOPSY OF RETROPERITONEAL LESIONS

DISCUSSION

BIOPSY OF RETROPERITONEAL LESIONS:

Depending on the size of the lesion and its location within the retroperitoneum,

either an anterior or posterior approach can be used,

although the posterior approach is usually preferred and is most often necessary to ensure a clear path for the use of cutting needles.

Page 29: GUIDED PERCUTANEOUS  BIOPSY OF RETROPERITONEAL LESIONS

CONCLUSION

Guided percutaneous biopsy of abdominal lesions

especially retroperitoneal lesions clearly has

become an important diagnostic tool.

The success of this technique lies in the accuracy

that can be achieved as well as in its relative safety

and ease of performance.